Industrial, Manufacturing & Heavy Industry Market News

The stock volume of fattened hogs was 715.57 million, up by 2.5% compared to 2012

China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total.

China Foot-and-mouth Disease (FMD) Vaccine Industry, 2014-2018 is a new market research publication announced by Reportstack. China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. According to the statistics of agricultural production from the National Bureau of Statistics of China, the annual output volume of poultry meat was 83.73 million tons in 2013, up by 1.8% YOY. The output volume of pork was 54.93 million tons, up by 2.8%. The stock volume of hogs was 474.11 million, down by 0.4% compared to 2012. The stock volume of fattened hogs was 715.57 million, up by 2.5% compared to 2012. In 2012, serious Type-A FMD broke out in Guangdong, Henan and Anhui. In 2013, Type-A FMD occurred in Guangxi and Guangdong. Therefore, it is necessary to inoculate pigs, cattle and sheep against FMD. 

According to the National Compulsory Immunization Plan of Animal Epidemic Diseases in China in 2013 issued by the Ministry of Agriculture, China implements compulsory immunity on four animal epidemic diseases including FMD while the expenses on the vaccines are undertaken by the government. Currently FMD vaccines are purchased by the government through invitation to bid in China. Driven by the large-scale cultivation, the demand for customized vaccines in large-scale farms keeps increasing. The market sales of vaccines grow rapidly. The market competition will be modest in the next 3-5 years due to high technical barriers of direct selling FMD vaccines and the small number of participated enterprises while the profit margin will remain at high level. 

Chinese government began to pay attention to the quality of vaccine products. In 2013, the bidding prices of FMD vaccines in Guangdong, Fujian and Shandong significantly depended on the quality. The standards for compulsory immunity vaccine purchasing are expected to be improved. The market competition will transfer from "low prices" to "high quality". Therefore, the prices of compulsory immunity vaccines, such as FMD vaccines, are expected to increase. 

As Chinese economy develops and the living standards improve, the demand for meat, meat products and dairy products keeps increasing, which stimulate the development of Chinese poultry industry and the demand for FMD vaccines. 

In the next few years, the market size of FMD vaccines will continue to increase rapidly in China with the average growth rate above 20%. 

Through this report, the readers can acquire the following information:
-Epidemic Status of FMD
-Status of China Breeding Industry
-Policy Environment and Government Procurement of FMD Vaccines in China
-Supply and Demand Status of FMD Vaccines in China
-Major Manufacturers of FMD Vaccines and the Operation Status in China
-Factors Influencing Development of FMD Vaccines in China
-Prospect of FMD Vaccine Industry in China

The Following Enterprises and People Are Recommended to Purchase This Report:
-Manufacturers and Trading Enterprises of Animal Vaccines
-Breeding Enterprises
-Management Organizations of Livestock Industry
-Investors and Research Institutes Concerned about FMD Vaccine Industry

To know more details please visit China Foot-and-mouth Disease (FMD) Vaccine Industry, 2014-2018.

For more information:

Make an Inquiry about this report HERE!

News From

Reportstack™ - Browse and Buy Market Research ReportsReportstack™
Category: Market Research Publishers and RetailersCompany about: Reportstack is one of the largest online libraries of market research publications. At Reportstack, users can find top-level research products from the leading publishers at one place. The best in practice web technology implemented by Reportstack enhances overall user experience and changes the way people buy research reports online. The market coverage spans across multiple verticals including but not limited to: Pharma & Healthcare, Automotive & Transport, Manufacturing & Industry ...
This email address is being protected from spambots. You need JavaScript enabled to view it.